XOCOVA gives pediatricians a new oral option to help prevent COVID-19 after exposure in adolescents aged 12 years and older.
Charles Vega, MD, FAAFP
Advertisement
Charles Vega, MD, FAAFP, is a Health Sciences Clinical Professor at the University of California, Irvine, School of Medicine.
Articles by Charles Vega, MD, FAAFP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
CDC-backed surveillance finds 4 in 5 child deaths preventable across 7 high-mortality countries
2
A teenaged girl with flat-topped papules
3
Bifidobacteria Decline: Causes and Consequences for Infant Gut Health
4
Semaglutide improves BMI category in children aged 6 to 11 years in phase 3 trial
5